Corus Pharma
Corus Pharma Inc, a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€378m (Public information from Oct 2006)
Seattle Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$18.5m | Series A | ||
$1.7m | Grant | ||
$40.0m | Series B | ||
$65.0m | Series C | ||
$25.0m | Late VC | ||
N/A | $416m Valuation: $416m | Acquisition | |
Total Funding | €137m |